SCHEMBL25985149

SCHEMBL25985149

COC(=O)c1cc(F)c2c(OC)cc(Br)nc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 1/20 0.46
PTPN11 Q06124 2/20 0.41
POLB P06746 2/20 0.39
CYP3A4 P08684 2/20 0.39
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GAA P10253 1/20 0.38
NFKB1 P19838 1/20 0.38
XDH P47989 1/20 0.38
GFER P55789 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
FUT7 Q11130 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NOTUM Q6P988 2/20 0.38
MAPT P10636 3/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25985150 0.79 SMN1; SMN2 (0.49) KDM4EALDH1A1LMNAGAAMAPT
SCHEMBL25985081 0.77 AXL (0.43) KDM4EALDH1A1PTPN11POLBCYP3A4
SCHEMBL25981002 0.75 MAPT (0.47) KDM4EALDH1A1L3MBTL1XDHNOTUM
SCHEMBL25984535 0.73 L3MBTL1 (0.44) KDM4EALDH1A1POLBL3MBTL1GAA
SCHEMBL583270 0.72 KDM4E (0.64) KDM4EALDH1A1PTPN11POLBLMNA
SCHEMBL20488880 0.71 KDM4E (0.55) KDM4EALDH1A1PTPN11POLBLMNA
SCHEMBL22655542 0.70 KDM4E (0.55) KDM4EALDH1A1PTPN11POLBCYP3A4
SCHEMBL583987 0.70 ALDH1A1 (0.79) KDM4EALDH1A1POLBLMNAL3MBTL1
SCHEMBL17184635 0.68 LMNA (0.50) KDM4EALDH1A1POLBCYP3A4LMNA
SCHEMBL17894021 0.68 LMNA (0.58) KDM4EALDH1A1PTPN11POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145599-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS MRJA THERAPEUTICS, INC. 2025-05-08 US disclosed
CN-118974019-A Certain chemical entities, compositions and methods 瑞图恩制药公司 2024-11-15 CN disclosed
WO-2023150663-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS RETUNE PHARMA INC. (US) 2023-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145599-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS IGF1R, IGFBP1, IGFBP2 KDM4E 3842/4885ALDH1A1 826/4885PTPN11 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.